Fig. 3From: Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangementsSankey diagram of treatment patterns (A) De novo patients; (B) Relapsed/ progressed patientsBack to article page